Reply by Authors
Notice bibliographique
Résumé
You have accessJournal of UrologyReview Article1 May 2021Reply by Authorsis a reply to letterEditorial Comment David-Dan Nguyen, Lorine Haeuser, Marco Paciotti, Chanan Reitblat, Jacqueline Cellini, Stuart R. Lipsitz, Adam S. Kibel, Atish D. Choudhury, Eugene B. Cone, and Quoc-Dien Trinh David-Dan NguyenDavid-Dan Nguyen Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Faculty of Medicine, McGill University, Montreal, QC, Canada More articles by this author , Lorine HaeuserLorine Haeuser Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , Marco PaciottiMarco Paciotti Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , Chanan ReitblatChanan Reitblat Harvard Medical School, Harvard University, Boston, Massachusetts More articles by this author , Jacqueline CelliniJacqueline Cellini Countway Library, Harvard Medical School, Harvard University, Boston, Massachusetts More articles by this author , Stuart R. LipsitzStuart R. Lipsitz Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , Adam S. KibelAdam S. Kibel Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , Atish D. ChoudhuryAtish D. Choudhury Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts More articles by this author , Eugene B. ConeEugene B. Cone Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , and Quoc-Dien TrinhQuoc-Dien Trinh *Correspondence: Harvard Medical School, Division of Urologic Surgery, Brigham and Women’s Hospital, 45 Francis St, Boston, Massachusetts , 02115 telephone: 617-525-7350; FAX: 617-525-6348; E-mail Address: [email protected] Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Financial interest and/or other relationship with Astellas, Bayer, Janssen and Intuitive Surgical. More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001601.02AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail We thank Albertsen for the insightful comment accompanying our systematic review examining the effect of time to definitive treatment on outcomes of intermediate risk and high risk prostate cancer. While our review question is based on the premise that earlier intervention for intermediate risk and high risk prostate cancer is associated with a benefit, our findings that delays do not impact mortality may provide some ecological basis to Hellman’s or Fischer’s models of cancer spread for prostate cancer.1 Our findings have added value in the context of the ongoing COVID-19 pandemic and for pandemics to come; they can help administrators and physicians better triage elective prostate cancer procedures. Specifically, one must weigh the risks associated with COVID-19 for the patient, personnel, equipment, and bed allocation against the oncological harms of delaying surgery. At the very least, our study may serve to reassure patients about the relative safety of delays in surgical care for prostate cancer. Reference 1. : Trends in metastatic breast and prostate cancer–lessons in cancer dynamics. N Eng J Med 2015; 373: 1685. Google Scholar © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyMar 11, 2021, 12:00:00 AMEditorial Comment Volume 205Issue 5May 2021Page: 1274-1274 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information David-Dan Nguyen Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Faculty of Medicine, McGill University, Montreal, QC, Canada More articles by this author Lorine Haeuser Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Marco Paciotti Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Chanan Reitblat Harvard Medical School, Harvard University, Boston, Massachusetts More articles by this author Jacqueline Cellini Countway Library, Harvard Medical School, Harvard University, Boston, Massachusetts More articles by this author Stuart R. Lipsitz Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Adam S. Kibel Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Atish D. Choudhury Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts More articles by this author Eugene B. Cone Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Quoc-Dien Trinh Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Division of Urological Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts *Correspondence: Harvard Medical School, Division of Urologic Surgery, Brigham and Women’s Hospital, 45 Francis St, Boston, Massachusetts , 02115 telephone: 617-525-7350; FAX: 617-525-6348; E-mail Address: [email protected] Financial interest and/or other relationship with Astellas, Bayer, Janssen and Intuitive Surgical. More articles by this author Expand All Advertisement Advertisement Loading ...
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,005 | 0,062 |
| Méta-épidémiologie (sens strict) | 0,001 | 0,001 |
| Méta-épidémiologie (sens large) | 0,001 | 0,002 |
| Bibliométrie | 0,001 | 0,001 |
| Études des sciences et des technologies | 0,004 | 0,003 |
| Communication savante | 0,005 | 0,006 |
| Science ouverte | 0,003 | 0,003 |
| Intégrité de la recherche | 0,023 | 0,032 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,051 | 0,048 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».